Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease
NCT05556135 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2022-09-27
Summary
Early detection of renal impairment in patients with Non-alcoholic fatty liver disease and its correlation with serum Adiponectin level.
Conditions
- Renal Impairment
Interventions
- DIAGNOSTIC_TEST
-
level of serun adiponectin
estimation of level of serum adiponectin in NAFLD for early detection of renal impairement
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
mohamed hassan, MD · master
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2023-10-31
- Completion
- 2023-10-31
More Related Trials
-
Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease
NCT06135467 ·Status: NOT_YET_RECRUITING
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
Assessment of Endothelial Function, Apolipoproteins and Adiponectin
NCT01300390 ·Status: COMPLETED
-
Weight Gain After Smoking Cessation and NAFLD
NCT05550688 ·Status: COMPLETED
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
NAFLD Among Patients With Type 2 Diabetes and CKD
NCT03826381 ·Status: COMPLETED
-
De Novo Lipogenesis in Severity of NAFLD
NCT03683589 ·Status: COMPLETED
-
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
NCT06135584 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines
NCT02799719 ·Status: COMPLETED
-
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
NCT05697991 ·Status: RECRUITING
-
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine
NCT03300661 ·Status: COMPLETED ·Phase: NA
-
Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT02649049 ·Status: COMPLETED
-
Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease
NCT05563259 ·Status: ENROLLING_BY_INVITATION
-
Resolution of Liver Fat in Non-alcoholic Fatty Liver Disease
NCT02558530 ·Status: COMPLETED ·Phase: NA
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
Effect of Fatty Liver Disease on Bone Density
NCT04850547 ·Status: UNKNOWN
-
Characterization of Serum Proteome in Young Obese Subjects (POSING)
NCT05761210 ·Status: COMPLETED
-
Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
NCT03986684 ·Status: COMPLETED
-
Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)
NCT01472120 ·Status: UNKNOWN
-
Characteristics of NAFLD Among Type 2 Diabetes Patients
NCT04999124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lifestyle Intervention in Fatty Liver (NAFLD)
NCT03354247 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT02812797 ·Status: COMPLETED
-
Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
NCT05685017 ·Status: COMPLETED
-
BeijngFH Health Cohort Study
NCT05546086 ·Status: RECRUITING
-
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02363309 ·Status: COMPLETED